EU OKs Bivalent COVID-19 Vaccines From Pfizer/BioNTech & Moderna

 
• By Ian Schofield

The European Commission will shortly issue marketing authorizations for bivalent versions of Comirnaty and Spikevax targeting the Omicron BA.1 subvariant, after the European Medicines Agency recommended their approval for EU-wide use. Bivalent Spikevax has also been provisionally approved in Australia.

spikevax and comirnaty
Bivalent versions of the two mRNA COVID-19 vaccines will soon be available in Europe • Source: Shutterstock

More from Europe

More from Geography